A detailed history of Brown Financial Advisory transactions in Abbott Laboratories stock. As of the latest transaction made, Brown Financial Advisory holds 1,804 shares of ABT stock, worth $209,083. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,804
Holding current value
$209,083
% of portfolio
0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$100.07 - $118.13 $180,526 - $213,106
1,804 New
1,804 $205,000
Q4 2023

Jan 25, 2024

BUY
$90.19 - $110.4 $171,721 - $210,201
1,904 New
1,904 $209,000
Q2 2023

Jul 21, 2023

BUY
$100.78 - $112.29 $191,885 - $213,800
1,904 New
1,904 $207,000
Q4 2022

Jan 25, 2023

BUY
$95.06 - $111.52 $180,994 - $212,334
1,904 New
1,904 $0

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Brown Financial Advisory Portfolio

Follow Brown Financial Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Financial Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Brown Financial Advisory with notifications on news.